108 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
. No relationship, direct or indirect, exists between or among the Company, on the one hand, and any director, officer, stockholder, customer or supplier
8-K
EX-14.1
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
operate, an outside business that is a significant competitor, supplier or customer of the Company;
be a consultant to, or a director, officer or employee
425
cjyu0h98u0p0pnt735
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
henfkg8wvdo89g1xrh52
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
EX-10.1
spvga36o
22 Jul 20
Entry into a Material Definitive Agreement
4:10pm
8-K/A
EX-10.2
p6nt5uc47htnmhy sfn
30 Dec 14
Departure of Directors or Certain Officers
12:00am
424B4
c5uh3ewmpgc
30 Dec 14
Prospectus supplement with pricing info
12:00am
8-K/A
EX-10.1
di7u21th
30 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
17tull tk9scwalmi
21 Nov 13
Arca Biopharma Announces Resignation from Board of Directors
12:00am
424B4
chs53f fbp
21 Nov 13
Prospectus supplement with pricing info
12:00am